# Chushin Venture Capital

> Chushin Venture Capital is a VC fund in Kyoto backing Biotechnology and Health Care. See 17 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Kyoto, Japan
- Total investments: 17
- Last investment: May 2026
- Lead investor: 0%
- Last updated: Aug 2026

Chushin Venture Capital is a venture capital fund established by Kyoto Chuo Shinkin Bank.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1.5M–$2M |
| Series A | $955k–$128M |
| Series B | $5.1M–$21M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 4 | 24% |
| Health Care | 3 | 18% |
| Manufacturing | 3 | 18% |
| Pharmaceutical | 3 | 18% |
| Medical | 2 | 12% |

31 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 6 | 35% |
| Seed | 3 | 18% |
| Series B | 3 | 18% |
| Series C | 3 | 18% |
| Venture - Series Unknown | 2 | 12% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Toregem BioPharma | Toregem BioPharma is a startup from Kyoto University that develops a treatment for congenital adentia. Toregem BioPharma is headquartered in Kyoto, Japan. | $5.3M | Series C | May 19, 2026 |  |
| Nexta | Nexta manufactures site, issues such as analog management, personalization of operations & labor shortages are becoming more serious. | $5.1M | Series B | Nov 26, 2025 |  |
| OOYOO | OOYOO is a Tech venture, which researches and development of gas separation membranes for carbon dioxide, hydrogen, etc. | $2M | Seed | Oct 15, 2025 |  |
| Cizucu | Cizucu is a stock photo community that helps creators and brands to create photos. |  | Seed | Jun 25, 2025 |  |
| HOLO BIO | HOLO BIO is a research and technology firm that employs biological breeding techniques to address the food challenges faced by humanity. | $1.5M | Seed | Jan 25, 2025 |  |
| MiCAN Technologies | MiCAN Technologies medical and nursing Care company we will provide the enabling tools to eliminate Malaria and other infectious diseases by the use of pluripotent stem cell. MiCAN Technologies through the provision of “blood cell-like cell products” produced using regenerative medicine technology,They will help you research malaria and otherinfectious and immune system diseases. | $1.6M | Venture - Series Unknown | Jan 24, 2025 |  |
| Regional Fish | Regional Fish provides seed, seedlings, aquaculture methods and fisheries services. | $19.1M | Series C | Dec 26, 2024 |  |
| RadioNano Therapeutics | RadioNano Therapeutics is developing innovative drugs for Boron Neutron Capture Therapy (BNCT), a type of radiation therapy that utilizes the nuclear reaction between thermal neutrons and boron-10 (¹⁰B) to destroy cancer cells by releasing alpha particles and lithium nuclei. | $954.7K | Series A | Dec 25, 2024 |  |
| Rege Nephro | Rege Nephro is a biotech company that specialized in R&D, production and marketing of renal disease therapeutics. | $15.2M | Series B | Oct 07, 2024 |  |
| Atomis | Atomis provides global solutions for precisely controlling gases. Its core technology, porous coordination polymers (PCPs; also known as metal-organic frameworks (MOFs)), is based on research developed by Distinguished Professor Susumu Kitagawa at the Institute for Advanced Study at Kyoto University. It aims not only to provide solutions such asthe optimization for manufacturing processes of PCPs but to also develop applications that provide innovative value using these materials.It was founded by Masakazu Higuchi in 2015 and is headquartered in Kyoto, Japan. |  | Series C | Jul 31, 2024 |  |

10 of 17 investments shown.

## Co-investors
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund, 5 deals together
- [Miraidoa](https://shizune.co/investors/profile/future-venture-capital) — VC Fund, 4 deals together
- [Kyoto University Innovation Capital](https://shizune.co/investors/profile/kyoto-university-innovation-capital) — VC Fund, 4 deals together
- [SMBC Venture Capital](https://shizune.co/investors/profile/smbc-venture-capital) — VC Fund, 4 deals together
- [Kyogin Lease & Capital](https://shizune.co/investors/profile/kyogin-lease-capital) — VC Fund, 3 deals together
- [Kyoto Capital Partners](https://shizune.co/investors/profile/kyoto-capital-partners) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [SVG Ventures](https://shizune.co/investors/profile/svg-ventures) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Omnivore](https://shizune.co/investors/profile/omnivore-partners) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund
- [SMBC Venture Capital](https://shizune.co/investors/profile/smbc-venture-capital) — VC Fund
- [Mizuho Capital](https://shizune.co/investors/profile/mizuho-capital) — VC Fund

## Featured in investor lists
- [Biotechnology Investors in Japan](https://shizune.co/investors/biotechnology-investors-japan)
- [Biotechnology VC Funds in Japan](https://shizune.co/investors/biotechnology-vc-funds-japan)
- [Biotech VC Funds in Japan](https://shizune.co/investors/biotech-vc-funds-japan)
- [Energy Investors in Japan](https://shizune.co/investors/energy-investors-japan)
- [Agriculture (agtech) Investors in Japan](https://shizune.co/investors/agriculture-agtech-investors-japan)
- [Agriculture (agtech) VC Funds in Japan](https://shizune.co/investors/agriculture-agtech-vc-funds-japan)

## FAQ

### What does Chushin Venture Capital invest in?

Chushin Venture Capital invests primarily in Biotechnology, Health Care and Manufacturing startups, most often at Series A and Seed stage. Most of the 17 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Chushin Venture Capital's check size?

Chushin Venture Capital typically joins rounds of $1.5M–$2M at Seed, $955k–$128M at Series A and $5.1M–$21M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Chushin Venture Capital participates in.

### When did Chushin Venture Capital last invest?

The most recent investment recorded for Chushin Venture Capital closed in May 2026. Shizune tracks 17 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co